SCHEMBL3650561

SCHEMBL3650561

CC(Oc1cc2sc(NC(=O)NCCNC(=O)O)nc2cc1F)c1c(Cl)ccc(F)c1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 17/20 0.42
KDR P35968 5/20 0.41
LCK P06239 2/20 0.40
FGFR2 P21802 2/20 0.40
AXL P30530 2/20 0.40
FLT3 P36888 2/20 0.40
MST1R Q04912 2/20 0.40
ABL1 P00519 2/20 0.40
AURKA O14965 1/20 0.40
FYN P06241 1/20 0.40
YES1 P07947 1/20 0.40
EPHA2 P29317 1/20 0.40
LTK P29376 1/20 0.40
PTK6 Q13882 1/20 0.40
SRC P12931 2/20 0.39
KIT P10721 1/20 0.39
ALK Q9UM73 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3652242 0.97 MET (0.41) METKDRLCKFGFR2AXL
SCHEMBL3102583 0.93 MET (0.42) METKDRLCKFGFR2AXL
SCHEMBL3097959 0.92 MET (0.43) METKDRLCKFGFR2AXL
SCHEMBL3110077 0.92 ABL1 (0.45) METKDRLCKFGFR2AXL
SCHEMBL3104496 0.92 MET (0.43) METKDRLCKFGFR2AXL
SCHEMBL3109366 0.92 ABL1 (0.45) METKDRLCKFGFR2AXL
SCHEMBL3098297 0.92 MET (0.43) METKDRLCKFGFR2AXL
SCHEMBL3104591 0.91 MET (0.42) METKDRLCKFGFR2AXL
SCHEMBL3102160 0.91 MET (0.42) METKDRLCKFGFR2AXL
SCHEMBL3102528 0.91 MET (0.42) METKDRLCKFGFR2AXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2205568-A1 6-ARYL/HETEROALKYLOXY BENZOTHIAZOLE AND BENZIMIDAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, APPLICATION THEREOF AS DRUGS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE IN PARTICULAR AS C-MET INHIBITORS Sanofi-Aventis (FR) 2010-07-14 EP disclosed
WO-2009087305-A1 6-ARYL/HETEROALKYLOXY BENZOTHIAZOLE AND BENZIMIDAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, APPLICATION THEREOF AS DRUGS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE IN PARTICULAR AS C-MET INHIBITORS SANOFI-AVENTIS (FR) 2009-07-16 WO disclosed